INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
7
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
344 sh
Jun 1, 2026Jun 2, 2026
Page 728 of 1724
← PrevNext →
traded Jun 1, 2026
+1d
SEC Form 4

Evidence

6
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise · 10b5-1 plan
M$179K
2,261 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

6
BH
Ber HedvaGlobal COO & Deputy CEO
ETOReToro Group Ltd.
Option exercise · 10b5-1 plan
M$90K
6,000 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

6
PJ
Petley Richard JChief Revenue Officer
TDCTERADATA CORP /DE/
Open-market sale · 10b5-1 plan
SELL$35K
990 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

6
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$710
200 sh
Jun 2, 2026Jun 2, 2026
traded Jun 2, 2026
+0dSEC Form 4

Evidence

6
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$136K
6,249 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

6
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$207K
9,375 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

6
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$121
34 sh
Jun 2, 2026Jun 2, 2026
traded Jun 2, 2026
+0dSEC Form 4

Evidence

5
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Option exercise
M—
5,301 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

5
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Option exercise
M—
742 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

5
GT
Gilbert Edward Terrell JrGC & CORPORATE SECRETARY
ASTEASTEC INDUSTRIES INC
Grant or award
A—
19 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

5
BH
Ber HedvaGlobal COO & Deputy CEO
ETOReToro Group Ltd.
Option exercise · 10b5-1 plan
M$362K
20.7K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

5
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Tax withholding
F$9,452
359 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

5
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Tax withholding
F$24K
3,028 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

5
XB
Xiang BiboChief Technology Officer
ATHMAutohome Inc.
Grant or award
A—
227.6K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

5
SC
Spice Adam C.Chief Financial Officer
RKLBRocket Lab Corp
Gift
G—
62.7K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

5
HA
Huet Melanie ArlenePresident, Home & Com - Home
NWLNEWELL BRANDS INC.
Option exercise
M—
1,943 sh
May 31, 2026Jun 2, 2026
traded May 31, 2026
+2dSEC Form 4

Evidence

5
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Option exercise
M—
2,140 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

5
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Grant or award
A—
5,718 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

5
HS
Hegna ShaunaDirector
NRIMNORTHRIM BANCORP INC
Grant or award
A—
1,456 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

5
SC
Spice Adam C.Chief Financial Officer
RKLBRocket Lab Corp
Gift
G—
62.7K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

5
FJ
Flores JessicaExecutive VP & CAO
SBRASabra Health Care REIT, Inc.
Grant or award
A—
385 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

5
EW
Ellingson Alan WayneChief Financial Officer
DKNGDraftKings Inc.
Tax withholding
F$26K
1,003 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

4
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
174.4K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

3
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

2
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$261K
5,000 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

1
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$150K
7,487 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

1
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$109K
2,515 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

0
BH
Ber HedvaGlobal COO & Deputy CEO
ETOReToro Group Ltd.
Option exercise · 10b5-1 plan
M—
20.7K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

0
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Tax withholding · 10b5-1 plan
F$1,102
331 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

0
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Option exercise · 10b5-1 plan
M—
387 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

0
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
5,000 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

0
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Tax withholding · 10b5-1 plan
F$16K
230 sh
Jun 2, 2026Jun 2, 2026
traded Jun 2, 2026
+0dSEC Form 4

Evidence

0
JI
Jeddi ImanSVP & GM da Vinci Platforms &
ISRGINTUITIVE SURGICAL INC
Option exercise · 10b5-1 plan
M—
5,625 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

0
BH
Ber HedvaGlobal COO & Deputy CEO
ETOReToro Group Ltd.
Option exercise · 10b5-1 plan
M—
6,000 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
174.4K sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC Form 4

Evidence

0
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
6,908 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

0
BH
Ber HedvaGlobal COO & Deputy CEO
ETOReToro Group Ltd.
Option exercise · 10b5-1 plan
M—
22.5K sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

0
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Tax withholding · 10b5-1 plan
F$230
69 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence

0
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
9,375 sh
Jun 1, 2026Jun 2, 2026
traded Jun 1, 2026
+1dSEC Form 4

Evidence